FBXO28 and pancreatic ductal adenocarcinoma: FBXO28 is also found to be upregulated in breast cancer (BC) and pancreatic ductal adenocarcinoma (PDAC), and high FBXO28 expression might serve as a poor prognostic factor for BC and PDAC [14, 15].